World Wires · story 26156 · unverified · 1 source(s)

Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day

Licaminlimab genotype-based precision medicine approach for TNFR1-mediated dry eye disease in PREDICT-1 registrational symptoms trial on track for topline

Open in the desk

Coverage

• Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day GlobeNewswire: public companies · tier D · clear net · 2026-10-07 06:00 UTC
• Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day GlobeNewswire: public companies · tier D · clear net · 2026-10-07 05:59 UTC

What this site indexes